CATH Domain 3wykA00

CATH Classification

Level	CATH Code	Description
	1	Mainly Alpha
	1.10	Orthogonal Bundle
	1.10.1300	Catalytic domain of cyclic nucleotide phosphodiesterase 4b2b
	1.10.1300.10	3'5'-cyclic nucleotide phosphodiesterase, catalytic domain

Domain Context

CATH Clusters

Superfamily	3'5'-cyclic nucleotide phosphodiesterase, catalytic domain
Functional Family	Phosphodiesterase 10A

Enzyme Information

3.1.4.17	3',5'-cyclic-nucleotide phosphodiesterase. based on mapping to UniProt Q9Y233 Nucleoside 3',5'-cyclic phosphate + H(2)O = nucleoside 5'-phosphate. -!- Acts on 3',5'-cyclic AMP, 3',5'-cyclic dAMP, 3',5'-cyclic IMP, 3',5'-cyclic GMP and 3',5'-cyclic CMP.
3.1.4.35	3',5'-cyclic-GMP phosphodiesterase. based on mapping to UniProt Q9Y233 Guanosine 3',5'-cyclic phosphate + H(2)O = guanosine 5'-phosphate.

UniProtKB Entries (1)

PDE10_HUMAN

Homo sapiens

CAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A

PDB Structure

PDB	3WYK
External Links	PDBSum Proteopedia
Method	X-RAY DIFFRACTION
Organism
Primary Citation	Discovery of 1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one (TAK-063), a highly potent, selective, and orally active phosphodiesterase 10A (PDE10A) inhibitor. Kunitomo, J., Yoshikawa, M., Fushimi, M., Kawada, A., Quinn, J.F., Oki, H., Kokubo, H., Kondo, M., Nakashima, K., Kamiguchi, N., Suzuki, K., Kimura, H., Taniguchi, T. J.Med.Chem.